ICPT logo

ICPT Depreciation And Amortization

ICPT Annual D&A

$592.00 K
-$2.22 M-78.96%

31 December 2022

1-Year Change

-78.96%
ICPT annual depreciation & amortization is down -78.96% year-on-year

3-Year Change

-83.84%
ICPT annual depreciation & amortization is down -83.84% over the past 3 years

All-time High

$4.60 M
ICPT annual depreciation & amortization is currently -87.13% below its historical high of $4.60 million
Annual Total Expenses$353.93 M
ICPT annual total expenses is $353.93 million
Annual Operating Expenses$352.94 M
ICPT annual total operating expenses is $352.94 million
Annual Revenue$285.71 M
ICPT annual revenue is $285.71 million
Annual Net Income$221.82 M
ICPT annual net profit is $221.82 million

ICPT Depreciation And Amortization Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ICPT Quarterly D&A

$97.00 K
+$7000.00+7.78%

30 September 2023

1-Year Change

+21.25%
ICPT quarterly depreciation & amortization is up +21.25% year-on-year

3-Year Change

-86.34%
ICPT quarterly depreciation & amortization is down -86.34% over the past 3 years

All-time High

$1.64 M
ICPT quarterly depreciation & amortization is currently -94.10% below its historical high of $1.64 million
Quarterly Total Expenses$87.15 M
ICPT quarterly total expenses is $87.15 million
Quarterly Operating Expenses$86.95 M
ICPT quarterly total operating expenses is $86.95 million
Quarterly Revenue$88.79 M
ICPT quarterly revenue is $88.79 million
Quarterly Net Income-$2.79 M
ICPT quarterly net profit is -$2.79 million

ICPT Quarterly D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ICPT TTM D&A

$377.00 K
+$17.00 K+4.72%

30 September 2023

1-Year Change

-56.91%
ICPT TTM depreciation & amortization is down -56.91% year-on-year

3-Year Change

-87.86%
ICPT TTM depreciation & amortization is down -87.86% over the past 3 years

All-time High

$5.16 M
ICPT TTM depreciation & amortization is currently -92.69% below its historical high of $5.16 million
Annual Total Expenses$353.93 M
ICPT annual total expenses is $353.93 million
Annual Operating Expenses$352.94 M
ICPT annual total operating expenses is $352.94 million
TTM Revenue$317.68 M
ICPT TTM revenue is $317.68 million
TTM Net Income-$61.61 M
ICPT TTM net profit is -$61.61 million

ICPT TTM D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ICPT Depreciation And Amortization Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-79.0%+21.3%-56.9%
3 y3 years-83.8%-86.3%-87.9%
5 y5 years-87.1%-91.4%-89.7%

ICPT Depreciation And Amortization High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time-87.1%-94.1%-92.7%

Intercept Pharmaceuticals Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sept 2023
-
$97.00 K(+7.8%)
$377.00 K(+4.7%)
June 2023
-
$90.00 K(+1.1%)
$360.00 K(+5.9%)
Mar 2023
-
$89.00 K(-11.9%)
$340.00 K(-42.6%)
Dec 2022
$592.00 K(-79.0%)
$101.00 K(+26.3%)
$592.00 K(-32.3%)
Sept 2022
-
$80.00 K(+14.3%)
$875.00 K(-44.1%)
June 2022
-
$70.00 K(-79.5%)
$1.56 M(-31.6%)
Mar 2022
-
$341.00 K(-11.2%)
$2.29 M(-18.8%)
Dec 2021
$2.81 M(-4.4%)
$384.00 K(-50.1%)
$2.81 M(-9.0%)
Sept 2021
-
$769.00 K(-2.8%)
$3.09 M(+1.9%)
June 2021
-
$791.00 K(-9.1%)
$3.03 M(-0.6%)
Mar 2021
-
$870.00 K(+31.6%)
$3.05 M(+3.6%)
Dec 2020
$2.94 M(-19.7%)
$661.00 K(-6.9%)
$2.94 M(-5.2%)
Sept 2020
-
$710.00 K(-12.1%)
$3.11 M(-6.2%)
June 2020
-
$808.00 K(+5.8%)
$3.31 M(-3.5%)
Mar 2020
-
$764.00 K(-7.3%)
$3.43 M(-6.3%)
Dec 2019
$3.66 M(-20.1%)
$824.00 K(-9.8%)
$3.66 M(-5.3%)
Sept 2019
-
$914.00 K(-1.6%)
$3.87 M(-5.1%)
June 2019
-
$929.00 K(-6.7%)
$4.08 M(-4.9%)
Mar 2019
-
$996.00 K(-3.4%)
$4.29 M(-6.4%)
Dec 2018
$4.58 M(-0.4%)
$1.03 M(-8.2%)
$4.58 M(-6.4%)
Sept 2018
-
$1.12 M(-1.3%)
$4.90 M(-5.0%)
June 2018
-
$1.14 M(-11.8%)
$5.16 M(+1.3%)
Mar 2018
-
$1.29 M(-4.1%)
$5.09 M(+10.6%)
Dec 2017
$4.60 M
$1.34 M(-2.7%)
$4.60 M(-6.1%)
DateAnnualQuarterlyTTM
Sept 2017
-
$1.38 M(+28.9%)
$4.90 M(+17.8%)
June 2017
-
$1.07 M(+33.7%)
$4.16 M(+5.4%)
Mar 2017
-
$802.00 K(-51.2%)
$3.95 M(+3.1%)
Dec 2016
$3.83 M(+126.6%)
$1.64 M(+155.7%)
$3.83 M(+35.9%)
Sept 2016
-
$643.00 K(-25.2%)
$2.82 M(+8.9%)
June 2016
-
$860.00 K(+25.7%)
$2.59 M(+21.8%)
Mar 2016
-
$684.00 K(+8.2%)
$2.13 M(+25.7%)
Dec 2015
$1.69 M(+281.7%)
$632.00 K(+53.0%)
$1.69 M(+30.9%)
Sept 2015
-
$413.00 K(+4.3%)
$1.29 M(+34.7%)
June 2015
-
$396.00 K(+58.4%)
$959.00 K(+51.9%)
Mar 2015
-
$250.00 K(+7.3%)
$631.30 K(+42.5%)
Dec 2014
$443.00 K(+317.9%)
$233.00 K(+191.3%)
$443.00 K(+87.2%)
Sept 2014
-
$80.00 K(+17.1%)
$236.60 K(+28.9%)
June 2014
-
$68.30 K(+10.7%)
$183.50 K(+26.6%)
Mar 2014
-
$61.70 K(+132.0%)
$145.00 K(+36.9%)
Dec 2013
$106.00 K(-47.3%)
$26.60 K(-1.1%)
$105.90 K(+3.6%)
Sept 2013
-
$26.90 K(-9.7%)
$102.20 K(+2.5%)
June 2013
-
$29.80 K(+31.9%)
$99.70 K(-33.4%)
Mar 2013
-
$22.60 K(-1.3%)
$149.60 K(-25.7%)
Dec 2012
$201.30 K(-51.0%)
$22.90 K(-6.1%)
$201.40 K(+12.8%)
Sept 2012
-
$24.40 K(-69.4%)
$178.50 K(+15.8%)
June 2012
-
$79.70 K(+7.1%)
$154.10 K(+107.1%)
Mar 2012
-
$74.40 K
$74.40 K
Dec 2011
$410.60 K(-14.4%)
-
-
Dec 2010
$479.50 K
-
-

FAQ

  • What is Intercept Pharmaceuticals annual depreciation & amortization?
  • What is the all time high annual D&A for Intercept Pharmaceuticals?
  • What is Intercept Pharmaceuticals annual D&A year-on-year change?
  • What is Intercept Pharmaceuticals quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Intercept Pharmaceuticals?
  • What is Intercept Pharmaceuticals quarterly D&A year-on-year change?
  • What is Intercept Pharmaceuticals TTM depreciation & amortization?
  • What is the all time high TTM D&A for Intercept Pharmaceuticals?
  • What is Intercept Pharmaceuticals TTM D&A year-on-year change?

What is Intercept Pharmaceuticals annual depreciation & amortization?

The current annual D&A of ICPT is $592.00 K

What is the all time high annual D&A for Intercept Pharmaceuticals?

Intercept Pharmaceuticals all-time high annual depreciation & amortization is $4.60 M

What is Intercept Pharmaceuticals annual D&A year-on-year change?

Over the past year, ICPT annual depreciation & amortization has changed by -$2.22 M (-78.96%)

What is Intercept Pharmaceuticals quarterly depreciation & amortization?

The current quarterly D&A of ICPT is $97.00 K

What is the all time high quarterly D&A for Intercept Pharmaceuticals?

Intercept Pharmaceuticals all-time high quarterly depreciation & amortization is $1.64 M

What is Intercept Pharmaceuticals quarterly D&A year-on-year change?

Over the past year, ICPT quarterly depreciation & amortization has changed by +$17.00 K (+21.25%)

What is Intercept Pharmaceuticals TTM depreciation & amortization?

The current TTM D&A of ICPT is $377.00 K

What is the all time high TTM D&A for Intercept Pharmaceuticals?

Intercept Pharmaceuticals all-time high TTM depreciation & amortization is $5.16 M

What is Intercept Pharmaceuticals TTM D&A year-on-year change?

Over the past year, ICPT TTM depreciation & amortization has changed by -$498.00 K (-56.91%)